The Barbadian government is proposing significant reforms to its drug regulatory system, with legislation now tabled in the Senate. These reforms aim to establish a new authority dedicated to enhancing oversight of medical products.
A key objective of this new authority is to improve access to essential medicines for the population. This initiative reflects a commitment to strengthening public health infrastructure and ensuring reliable access to necessary pharmaceutical products.
The tabling of this legislation indicates a formal step towards modernizing and centralizing the regulatory framework for drugs. The proposed changes are designed to bring greater structure and efficiency to the oversight process.
Source: Barbados Today | Published: Wed, 10 Jun 2026 22:30:15 GMT
Leave a Reply